⌘K

Login Start Free

Home/Filings/4/0001144204-14-006637

4//SEC Filing

MEDGENICS, INC. 4

Accession 0001144204-14-006637

CIK 0001138776operating

View on SEC.gov Company Profile

Filed

Feb 5, 7:00 PM ET

Accepted

Feb 6, 6:02 PM ET

Size

13.7 KB

Accession

0001144204-14-006637

Insider Transaction Report

Form 4

Period: 2014-02-04

MEDGENICS, INC.MDGN

Pearlman Andrew

President and CEO

Transactions

Exercise/Conversion
Common Stock
2014-02-04$3.14/sh+3,200$10,048→ 60,562 total
Exercise/Conversion
Option Award (right to buy)
2014-02-04−16,800→ 92,006 total
Exercise: $2.49Exp: 2014-09-13→ Common Stock (16,800 underlying)
Exercise/Conversion
Option Award (right to buy)
2014-02-04−3,200→ 45,800 total
Exercise: $3.14Exp: 2014-09-13→ Common Stock (3,200 underlying)
Exercise/Conversion
Common Stock
2014-02-04$2.49/sh+16,800$41,832→ 57,362 total
Sale
Common Stock
2014-02-04$8.00/sh−20,000$160,000→ 40,562 total

Holdings

Common Stock
(indirect: By Spouse)
94
Common Stock
(indirect: By LLC)
1,719

Footnotes (2)

[F1]The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 23, 2013.
[F2]The option award became fully exercisable on September 13, 2013 in accordance with the terms of the reporting person's separation agreement entered into upon his resignation as the issuer's President and Chief Executive Officer.

Documents

1 file

4
v367452_4.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

MEDGENICS, INC.

CIK 0001138776

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0001138776

Filing Metadata

Form type: 4
Filed: Feb 5, 7:00 PM ET
Accepted: Feb 6, 6:02 PM ET
Size: 13.7 KB

View on SEC.gov